Covaxin: Bharat Biotech to conduct Phase-3 clinical trials in 26,000 volunteers
India | Oct 23, 2020, 06:53 PM ISTBharat Biotech, a leading vaccine maker which is developing India's own vaccine for coronavirus named COVAXIN said it has successfully completed interim analysis of Phase I and II trials and is initiating Phase-III trials in 26,000 participants.